Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events.
Bissonnette R, Eichenfield LF, Simpson E, Thaçi D, Kabashima K, Thyssen JP, Guttman-Yassky E, Nunes FP, Gamalo M, Ahmad F, Kuligowski M, Sun K, Pipper C, Christensen AW, D'Angelo P, Milutinovic M, Guettner A, Silverberg JI. Bissonnette R, et al. Among authors: guettner a. J Eur Acad Dermatol Venereol. 2023 May;37(5):976-983. doi: 10.1111/jdv.18881. Epub 2023 Feb 25. J Eur Acad Dermatol Venereol. 2023. PMID: 36652273 Review.
The FDA's Final Rule on Expedited Safety Reporting: Statistical Considerations.
Wittes J, Crowe B, Chuang-Stein C, Guettner A, Hall D, Jiang Q, Odenheimer D, Xia HA, Kramer J. Wittes J, et al. Among authors: guettner a. Stat Biopharm Res. 2015 Jul 3;7(3):174-190. doi: 10.1080/19466315.2015.1043395. Epub 2015 Oct 9. Stat Biopharm Res. 2015. PMID: 26550466 Free PMC article.
Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial.
Paul C, Reich K, Gottlieb AB, Mrowietz U, Philipp S, Nakayama J, Harfst E, Guettner A, Papavassilis C; CAIN457A2211 study group. Paul C, et al. Among authors: guettner a. J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1670-5. doi: 10.1111/jdv.12359. Epub 2014 Jan 7. J Eur Acad Dermatol Venereol. 2014. PMID: 24393602 Clinical Trial.
Item-level psychometric properties for a new patient-reported psoriasis symptom diary.
Strober BE, Nyirady J, Mallya UG, Guettner A, Papavassilis C, Gottlieb AB, Elewski BE, Turner-Bowker DM, Shields AL, Gwaltney CJ, Lebwohl M. Strober BE, et al. Among authors: guettner a. Value Health. 2013 Sep-Oct;16(6):1014-22. doi: 10.1016/j.jval.2013.07.002. Value Health. 2013. PMID: 24041351 Free article. Clinical Trial.
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
Rich P, Sigurgeirsson B, Thaci D, Ortonne JP, Paul C, Schopf RE, Morita A, Roseau K, Harfst E, Guettner A, Machacek M, Papavassilis C. Rich P, et al. Among authors: guettner a. Br J Dermatol. 2013 Feb;168(2):402-11. doi: 10.1111/bjd.12112. Br J Dermatol. 2013. PMID: 23362969 Clinical Trial.
Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial.
Bangert C, Strober BE, Cork M, Ortonne JP, Luger T, Bieber T, Ferguson A, Ecker RC, Kopp T, Weise-Riccardi S, Guettner A, Stingl G. Bangert C, et al. Among authors: guettner a. Dermatology. 2011 Feb;222(1):36-48. doi: 10.1159/000321711. Epub 2010 Dec 8. Dermatology. 2011. PMID: 21150167 Clinical Trial.